Text Size

Collection of Bone Marrow Aspirate From Volunteer Donors

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Institute on Aging (NIA) )
ClinicalTrials.gov Identifier:
NCT00183066
First received: September 13, 2005
Last updated: August 3, 2012
Last verified: August 2012
History of Changes
  Purpose

The purpose of this study is to collect bone marrow cells for research purposes.


Condition
Aging

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Collection of Bone Marrow Aspirate From Volunteer Donors for In Vitro Hematopoietic Research

Further study details as provided by National Institutes of Health Clinical Center (CC):

Biospecimen Retention:   Samples With DNA

Bone marrow aspirates Whole blood


Enrollment: 63
Study Start Date: July 2002
Study Completion Date: August 2012
Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)
Detailed Description:

This study is designed to provide bone marrow cells for other research studies. The research is being done because there are ongoing experiments in a number of National Institute on Aging (NIA) laboratories that require access to normal human bone marrow aspirate for their studies of the immune system. These studies are done to understand how blood cells are formed and how they function. Samples will be used to study problems such as the immune system in bone marrow failure and related conditions. Cells will be used in laboratory research and may be banked for future laboratory studies

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Healthy males and females 18 years and older

Criteria

Inclusion Criteria:

  • Healthy volunteers age 18 and over

Exclusion Criteria:

  • Significant abnormalities on health history questionnaire or in the results of blood tests
  • Pregnant or nursing mother
  • Participation in another research study within the past six weeks that is felt by the Principal Investigator to be incompatible with this study
  • Severe infection in the past two months
  • Immune disorder, or use of any medication that can alter immune system function
  • A medical or mental health finding showing inability to go through the procedure
  • Body mass index (BMI) greater than 29%
  • Chronic back pain, sciatica, or a compression fracture of the spine
  • Positive test results for viral infections: Hepatitis B, Hepatitis C, or HIV (AIDS)
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00183066

Locations
United States, Maryland
NIA Clinical Research Unit located at Harbor Hospital
Baltimore, Maryland, United States, 21225
Sponsors and Collaborators
National Institute on Aging (NIA)
Investigators
Principal Investigator: Dan L. Longo, MD National Institute on Aging (NIA)
  More Information

Additional Information:
National Institute on Aging  This link exits the ClinicalTrials.gov site

Publications:

Responsible Party: National Institutes of Health Clinical Center (CC) ( National Institute on Aging (NIA) )
ClinicalTrials.gov Identifier: NCT00183066     History of Changes
Other Study ID Numbers: AG0046
Study First Received: September 13, 2005
Last Updated: August 3, 2012
Health Authority: United States: Federal Government

ClinicalTrials.gov processed this record on May 19, 2013